Your browser doesn't support javascript.
loading
Associations Between Mean HbA1c, HbA1c Variability, and Both Mortality and Macrovascular Complications in Patients with Diabetes Mellitus: A Registry-Based Cohort Study.
Tan, Joshua Kuan; Lim, Gek Hsiang; Mohamed Salim, Nur Nasyitah; Chia, Sing Yi; Thumboo, Julian; Bee, Yong Mong.
Afiliação
  • Tan JK; Health Services Research Unit, Singapore General Hospital, Singapore, 169608, Singapore.
  • Lim GH; Health Services Research Unit, Singapore General Hospital, Singapore, 169608, Singapore.
  • Mohamed Salim NN; Health Services Research Unit, Singapore General Hospital, Singapore, 169608, Singapore.
  • Chia SY; Health Services Research Unit, Singapore General Hospital, Singapore, 169608, Singapore.
  • Thumboo J; Health Services Research Unit, Singapore General Hospital, Singapore, 169608, Singapore.
  • Bee YM; Department of Endocrinology, Singapore General Hospital, Singapore, 169608, Singapore.
Clin Epidemiol ; 15: 137-149, 2023.
Article em En | MEDLINE | ID: mdl-36721457
ABSTRACT

Background:

We investigate the association between mean HbA1c, HbA1c variability, and all-cause mortality and diabetes-related macrovascular complications in patients with diabetes.

Methods:

We performed a retrospective cohort study using patients present in the Singapore Health Services diabetes registry (SDR) during 2013 to 2014. We assessed mean HbA1c using three models a baseline mean HbA1c for 2013-14, the mean across the whole follow-up period, and a time-varying yearly updated mean. We assessed HbA1c variability at baseline using the patient's HbA1c variability score (HVS) for 2013-14. The association between mean HbA1c, HVS, and 6 outcomes were assessed using Cox proportional hazard models.

Results:

We included 43,837-53,934 individuals in the analysis; 99.3% had type 2 diabetes mellitus. The data showed a J-shaped distribution in adjusted hazard ratios (HRs) for all-cause mortality, ischemic heart disease, acute myocardial infarction, peripheral arterial disease, and ischemic stroke, with an increased risk of developing these outcomes at HbA1c <6% (42 mmol/mol) and ≥8% (64 mmol/mol). With the addition of HVS, the J-shaped distribution was maintained for the above outcomes, but HRs were greater at HbA1c <6.0% (42 mmol/mol) and reduced at HbA1c ≥8.0% (64 mmol/mol) when compared to models without HVS. The risk for all outcomes increased substantially with increasing glycaemic variability.

Conclusion:

Both low (<6.0% [42 mmol/mol]) and high (≥8.0% [64 mmol/mol]) levels of glycaemic control are associated with increased all-cause mortality and diabetes-related macrovascular complications. Glycaemic variability is independently associated with increased risk for these outcomes. Therefore, patients with stable glycaemic level of 6-8% (42-64mmol/mol) are at lowest risk of all-cause mortality and diabetes-related macrovascular complications.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article